Chart — Mental Health
Depression vs Bipolar Disorder Comparison
Major depressive disorder and bipolar disorder share depressive symptoms but differ critically in mood pattern, treatment, and nursing priorities. This chart compares key features side by side for NCLEX preparation and clinical practice.
Educational use only. Mood disorder diagnosis requires comprehensive psychiatric evaluation. This chart is for nursing education and NCLEX preparation. This material supports nursing education and exam review. It is not medical advice and is not a substitute for clinical judgment, institutional policy, or medical direction. Always follow facility protocols and current provider orders.
NCLEX Key Distinction: Decreased need for sleep without fatigue during mania is the hallmark that distinguishes a manic episode from depression. Antidepressant monotherapy is contraindicated in bipolar disorder — it can precipitate mania or mixed states.
Feature Comparison
| Feature | Major Depression | Bipolar Disorder |
|---|---|---|
| Core Mood Disturbance | Persistent depressed mood; hopelessness; emptiness for ≥2 weeks | Cycling between depressed and elevated/irritable mood episodes; both poles may occur |
| Mood Elevation | Absent — no manic or hypomanic episodes (if present, reconsider diagnosis) | Mania (Bipolar I) or hypomania (Bipolar II) required for diagnosis; may feel euphoric, irritable, or 'on top of the world' |
| Sleep Pattern | Insomnia (most common) or hypersomnia; early morning awakening in melancholic depression | Decreased need for sleep without fatigue during mania (key distinguishing feature); insomnia or hypersomnia during depression |
| Energy Level | Fatigue, low energy, psychomotor retardation or agitation | High energy, increased goal-directed activity during mania; fatigue and retardation during depressive episodes |
| Thought Content | Negative, hopeless, worthless; ruminative; death ideation or suicidal thoughts | Grandiose during mania ('I have special powers'); hopeless and suicidal during depression; mixed states are highest suicide risk |
| Thought Process / Speech | Slowed, quiet, monotone; poverty of speech in severe cases | Pressured speech, flight of ideas, rapid topic-changing during mania; slowed speech during depression |
| Suicidal Risk | High — especially with hopelessness, prior attempts, social isolation | Very high — 15–20× general population; highest during depressive and mixed episodes; assess at every encounter |
| Impulsivity | Low — patients are typically withdrawn, not impulsive | High during mania — risky sexual behavior, financial recklessness, substance use, dangerous activities; poor judgment |
| Insight | Often preserved — patient recognizes being unwell and may seek help | Often impaired during mania — patient may not recognize the episode as pathological; may resist treatment to maintain euphoria |
| First-Line Medications | SSRIs (fluoxetine, sertraline, escitalopram); SNRIs; onset 2–6 weeks | Mood stabilizers (lithium, valproate, lamotrigine); atypical antipsychotics for mania; antidepressants alone are avoided (may trigger mania) |
| Antidepressant Use | First-line treatment — SSRIs/SNRIs are cornerstone of pharmacotherapy | Caution — antidepressant monotherapy can trigger manic or mixed episodes; use only with a mood stabilizer if indicated |
| Key Nursing Priority | Suicide risk assessment; therapeutic relationship; medication education (2–6 week delay); monitor for early suicidal ideation increase with SSRI initiation | Safety during both poles; lithium level monitoring; nutritional support during mania; medication adherence; early warning sign recognition |
| Misdiagnosis Risk | May be diagnosed in patients who actually have Bipolar II (depressive phase without recognized hypomania) | Bipolar II frequently misdiagnosed as unipolar depression — ask specifically about periods of elevated mood, decreased sleep without fatigue, increased activity |
| Course | May be a single episode or recurrent; between episodes, functioning is typically restored | Chronic, lifelong course with episode cycling; functional impairment accumulates without consistent treatment |
Nursing Priorities at a Glance
Major Depression
- Safety — assess suicidal ideation at every encounter
- Therapeutic relationship — non-judgmental presence
- Educate: SSRI/SNRI onset 2–6 weeks, do not stop abruptly
- Monitor for increased suicidality in first 1–2 weeks of medication initiation
- Support physical needs: nutrition, sleep, activity
- Crisis resources: 988 Lifeline
Bipolar Disorder
- Safety — highest risk during mixed and depressive episodes
- During mania: low-stimulation environment, firm limits, finger foods
- Lithium monitoring: therapeutic level 0.6–1.2 mEq/L; toxicity >1.5 mEq/L
- Teach medication adherence — missed doses cause rapid relapse
- Teach early warning signs: sleep changes often first indicator
- Avoid antidepressant monotherapy
Related Resources
Standards & sources
Fact-checked Jun 21, 2026This page is written to align with American Psychiatric Association (DSM-5-TR) · American Psychiatric Nurses Association (APNA) · SAMHSA. It is an educational summary, not a citation of any single document — always verify specific doses, values, and protocols against current guidelines and your facility policy. How we source content →